4 RESULTS
COMMENT Aβ immunotherapy has been considered as a treatment for Alzheimer’s disease for some years; however, the lack of clear cognitive efficiency associated with the presence of side effects in some patients has tempered enthusiasm. Nevertheless, the recent ...
COMMENT As investigators focused on direct study of inflammatory processes in the human brain, we are impressed by the spectacular application of new technology to Alzheimer’s disease in this paper. The findings resonate in two specific ways with our own previous ...
COMMENT This study measured plasma levels of four acute phase proteins (fibrinogen, albumin, von Willebrand factor and Factor VIII) and white cell count in a mixed-race, middle-age group of 1,633 subjects with later assessment of episodic memory and 3T MRI brain ...
COMMENT A Multimodal Drug to Target Alzheimer’s Disease This paper describes the identification of a new RAGE (receptor for advanced glycation endproducts) blocker. Using in-vitro techniques and transgenic AD mice, the authors show that the compound FPS-ZM1: 1) ...
